公开(公告)号：US20240216342A1

公开(公告)日：2024-07-04

申请号：US18556912

申请日：2022-04-27

Applicant: KOWA COMPANY, LTD.

Inventor： Ryohei TANIGAWA ,  Ayumi SAITO ,  Kaho IKEGAMI

IPC: A61K31/423 ,  A61K31/205 ,  A61P3/00

CPC classification number: A61K31/423 ,  A61K31/205 ,  A61P3/00

Abstract: Provided is a novel preventing and/or treating agent useful for prevention and/or treatment of carnitine deficiency, or a disease for which supplementation of carnitine may have a therapeutic effect. The present invention relates to a medicament for preventing and/or treating carnitine deficiency, or a disease for which supplementation of carnitine may have a therapeutic effect, the medicament comprising a therapeutically effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy]butyric acid, a salt thereof, or a solvate thereof.